|
US6344321B1
(en)
|
1990-06-11 |
2002-02-05 |
Gilead Sciences, Inc. |
Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met
|
|
DK1621554T4
(da)
|
1992-08-21 |
2012-12-17 |
Univ Bruxelles |
Immunoglobuliner blottet for lette kæder
|
|
GB9710807D0
(en)
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
|
GB9710809D0
(en)
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
|
US6140081A
(en)
|
1998-10-16 |
2000-10-31 |
The Scripps Research Institute |
Zinc finger binding domains for GNN
|
|
US6453242B1
(en)
|
1999-01-12 |
2002-09-17 |
Sangamo Biosciences, Inc. |
Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
|
|
US6534261B1
(en)
|
1999-01-12 |
2003-03-18 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
|
JP2002060786A
(ja)
|
2000-08-23 |
2002-02-26 |
Kao Corp |
硬質表面用殺菌防汚剤
|
|
JP2005500061A
(ja)
|
2001-08-20 |
2005-01-06 |
ザ スクリップス リサーチ インスティテュート |
Ｃｎｎについての亜鉛フィンガー結合ドメイン
|
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
US7972854B2
(en)
|
2004-02-05 |
2011-07-05 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
US8574179B2
(en)
|
2004-09-17 |
2013-11-05 |
Stp Swiss Therapeutic Products Ag |
Enhanced biomechanical stimulation device
|
|
JP5813321B2
(ja)
|
2007-03-23 |
2015-11-17 |
ウィスコンシン アラムニ リサーチ ファンデーション |
体細胞の再プログラム化
|
|
EP3279314A1
(en)
|
2008-06-04 |
2018-02-07 |
Cellular Dynamics International, Inc. |
Methods for the production of ips cells using non-viral approach
|
|
DK2356221T3
(en)
|
2008-10-24 |
2019-02-18 |
Wisconsin Alumni Res Found |
Pluripotent stem cells obtained by non-viral reprogramming
|
|
KR101720961B1
(ko)
|
2009-02-27 |
2017-03-29 |
셀룰러 다이내믹스 인터내셔널, 인코포레이티드 |
다능성 세포의 분화
|
|
US9056841B2
(en)
|
2009-03-19 |
2015-06-16 |
The Johns Hopkins University |
PSMA-targeting compounds and uses thereof
|
|
WO2011072246A2
(en)
|
2009-12-10 |
2011-06-16 |
Regents Of The University Of Minnesota |
Tal effector-mediated dna modification
|
|
US9206394B2
(en)
*
|
2010-02-03 |
2015-12-08 |
The University Of Tokyo |
Method for reconstructing immune function using pluripotent stem cells
|
|
CA2806858C
(en)
|
2010-08-04 |
2021-06-15 |
Cellular Dynamics International, Inc. |
Reprogramming immortalized b cells
|
|
CA2826386C
(en)
|
2011-02-08 |
2020-04-28 |
FUJIFILM Cellular Dynamics, Inc. |
Hematopoietic precursor cell production by programming
|
|
DE102012006356A1
(de)
|
2012-03-28 |
2013-10-02 |
Audi Ag |
Kraftfahrzeug, umfassend mehrere aktive oder passive Sicherheitsvorrichtungen
|
|
WO2014165707A2
(en)
*
|
2013-04-03 |
2014-10-09 |
Memorial Sloan-Kettering Cancer Center |
Effective generation of tumor-targeted t-cells derived from pluripotent stem cells
|
|
US11124845B2
(en)
|
2014-03-18 |
2021-09-21 |
The Johns Hopkins University |
PSMA-based molecular-genetic reporter system
|
|
JP6715482B2
(ja)
|
2014-07-18 |
2020-07-01 |
国立大学法人京都大学 |
多能性幹細胞から免疫細胞療法用ｔ細胞を誘導する方法
|
|
US10947502B2
(en)
|
2015-10-20 |
2021-03-16 |
FUJIFILM Cellular Dynamics, Inc. |
Methods for directed differentiation of pluripotent stem cells to immune cells
|
|
AU2016361451B2
(en)
*
|
2015-11-27 |
2024-01-25 |
Cartherics Pty. Ltd. |
Genetically modified cells and uses thereof
|
|
LT3444334T
(lt)
|
2016-04-15 |
2021-12-10 |
Kyoto University |
Antigenui specifinių cd8 teigiamų t ląstelių indikavimo būdas
|
|
KR20230167769A
(ko)
|
2016-08-26 |
2023-12-11 |
베이롤 칼리지 오브 메드신 |
세포 치료요법을 위한 항상성 활성 사이토킨 수용체
|
|
US11525119B2
(en)
|
2016-09-06 |
2022-12-13 |
The Children's Medical Center Corporation |
Immune cells derived from induced pluripotent stem cell
|
|
CN109996868A
(zh)
|
2016-09-23 |
2019-07-09 |
弗雷德哈钦森癌症研究中心 |
特异性用于次要组织相容性(h)抗原ha-1的tcr及其用途
|
|
AU2017340644B2
(en)
|
2016-10-05 |
2024-05-09 |
FUJIFILM Cellular Dynamics, Inc. |
Methods for directed differentiation of pluripotent stem cells to HLA homozygous immune cells
|
|
MX2019012017A
(es)
|
2017-04-07 |
2020-02-12 |
Juno Therapeutics Inc |
Celulas modificadas que expresan antigeno de membrana especifico de prostata (psma) o una forma modificada del mismo y metodos relacionados.
|
|
SG11201909331UA
(en)
|
2017-04-18 |
2019-11-28 |
Fujifilm Cellular Dynamics Inc |
Antigen-specific immune effector cells
|
|
CA3070998A1
(en)
|
2017-07-25 |
2019-01-31 |
Board Of Regents, The University Of Texas System |
Enhanced chimeric antigen receptors and use thereof
|
|
WO2019060695A1
(en)
|
2017-09-22 |
2019-03-28 |
Kite Pharma, Inc. |
CHIMERIC POLYPEPTIDES AND USES THEREOF
|
|
EP4269560A3
(en)
|
2017-10-03 |
2024-01-17 |
Precision Biosciences, Inc. |
Modified epidermal growth factor receptor peptides for use in genetically-modified cells
|
|
WO2020061256A1
(en)
|
2018-09-19 |
2020-03-26 |
FUJIFILM Cellular Dynamics, Inc. |
Protein l for activation and expansion of chimeric antigen receptor-modified immune cells
|
|
MX2021006194A
(es)
*
|
2018-12-02 |
2021-06-30 |
Fate Therapeutics Inc |
Inmunoterapias mediante el uso de celulas efectoras potenciadas derivadas de ipsc.
|
|
US12241061B2
(en)
*
|
2019-02-04 |
2025-03-04 |
National University Corporation Ehime University |
CAR library and scFv manufacturing method
|
|
PE20211959A1
(es)
*
|
2019-02-15 |
2021-09-30 |
Editas Medicine Inc |
Celulas asesinas naturales (nk) modificadas para inmunoterapia
|
|
CN115551882A
(zh)
*
|
2020-01-31 |
2022-12-30 |
希望之城公司 |
用于治疗IL13Rα2阳性恶性病的靶向性嵌合抗原受体修饰的T细胞
|